Related Experiment Videos
Phosphotyrosine antibodies as probes for activated oncogene products endowed with tyrosine kinase activity
M Prat1, M F Di Renzo, G Gaudino
1Dipartimento di Scienze Biomediche e Oncologia, Università degli Studi, Turin, Italy.
Abstract:
The usefulness of phosphotyrosine antibodies for the detection of physiologically regulated or deregulated kinases is shown in this paper. This rather rare enzymatic activity is shared by receptors for some polypeptide growth factors and by the products of class 1 oncogenes. The antibodies are able to detect proteins phosphorylated on tyrosine in fibroblasts stimulated with growth factors, such as EGF and PDGF. The major phosphorylated protein species are the receptors themselves, which undergo phosphorylation only following the addition of the exogenous factor and only transiently. Phosphotyrosine antibodies were able to detect the products of the retroviral class 1 oncogenes, which are endowed of deregulated tyrosine kinase activity. In fact, in these cases a constitutive phosphorylation of the relevant proteins was observed, which occurred continuously and independently of the presence or lack of the growth factor. A tyrosine kinase constitutively activated in human gastric carcinoma cells was detected by P-Tyr antibodies. This molecule has been characterized at molecular level and the mechanisms responsible for its enzymatic activation has been investigated. The question of whether the tyrosine kinase identified is responsible for the induction and the maintenance of the transformed phenotype in gastric carcinomas remains to be answered. It is reasonable to suggest that this might be the case by analogy with other known pathologies, such as class 1 oncogenes activated by transduction by retroviruses, abnormal expression of EGF receptors or deregulated activity of c-abl encoded proteins in CML and ALL. Thus, the search for deregulated kinases by means of phosphotyrosine antibodies seems to be useful for identifying new activated oncogenes in clinical oncology.
Insights
Phosphotyrosine antibodies detect tyrosine kinases involved in cell growth and cancer. These antibodies identify both normal growth factor signaling and abnormal oncogene activity, aiding in cancer research.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Tyrosine kinase activity is crucial in cell signaling, growth factor response, and oncogenesis.
- Phosphotyrosine antibodies offer a method to study this rare enzymatic activity.
- Deregulated tyrosine kinases are implicated in various cancers.
Purpose of the Study:
- To demonstrate the utility of phosphotyrosine antibodies for detecting physiologically regulated and deregulated kinases.
- To investigate the role of tyrosine kinases in growth factor signaling and oncogene activation.
- To explore the potential of phosphotyrosine antibodies in identifying novel oncogenes in clinical oncology.
Main Methods:
- Utilizing phosphotyrosine antibodies to detect phosphorylated proteins in stimulated fibroblasts and cancer cells.
- Analyzing protein phosphorylation patterns in response to growth factors (EGF, PDGF) and in the presence of oncogenes.
- Molecular characterization of a constitutively activated tyrosine kinase in gastric carcinoma cells.
Main Results:
- Phosphotyrosine antibodies successfully detected transient tyrosine phosphorylation of growth factor receptors (EGF, PDGF) upon stimulation.
- These antibodies identified constitutively phosphorylated proteins associated with retroviral class 1 oncogenes, indicating deregulated kinase activity.
- A constitutively activated tyrosine kinase was detected and characterized in human gastric carcinoma cells.
Conclusions:
- Phosphotyrosine antibodies are valuable tools for identifying both normal and aberrant tyrosine kinase activity.
- The detection of a constitutively activated kinase in gastric cancer suggests its potential role in tumorigenesis.
- This approach holds promise for discovering new activated oncogenes in clinical cancer settings.